Metabolic dysfunction-associated fatty liver disease in people living with HIV

Abstract The prevalence of metabolic risk factors and non-alcoholic fatty liver disease (NAFLD) is high among people living with HIV (PLWH). Data on the recently proposed definition of metabolic dysfunction-associated fatty liver disease (MAFLD) in PLWH receiving antiretroviral therapy (ART) remains...

Full description

Bibliographic Details
Published in:	Scientific Reports
Main Authors:	Maurice Michel, Christian Labenz, Angelo Armandi, Leonard Kaps, Wolfgang Maximilian Kremer, Peter R. Galle, Daniel Grimm, Martin Sprinzl, Jörn M. Schattenberg
Format:	Article
Language:	English
Published:	Nature Portfolio 2023-06-01
Online Access:	https://doi.org/10.1038/s41598-023-32965-y

Similar Items

Effect of hepatic steatosis and associated metabolic comorbidities on health‐related quality of life in people living with HIV
by: Maurice Michel, et al.
Published: (2022-08-01)

Impairment of health-related quality of life among people with type 2 diabetes and advanced liver fibrosis
by: Maurice Michel, et al.
Published: (2024-09-01)

Liver Frailty Index for Prediction of Short-Term Rehospitalization in Patients with Liver Cirrhosis
by: Leonard Kaps, et al.
Published: (2022-04-01)

Evaluation of IL‐6 for Stepwise Diagnosis of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis
by: Simon Johannes Gairing, et al.
Published: (2022-05-01)

Nonalcoholic Fatty Liver Disease Increases the Risk of Anxiety and Depression
by: Christian Labenz, et al.
Published: (2020-09-01)

Variability of transient elastography-based spleen stiffness performed at 100 Hz
by: Angelo Armandi, et al.
Published: (2023-12-01)

Portal vein thrombosis is associated with an increased risk of bone fractures.
by: Simon Johannes Gairing, et al.
Published: (2022-01-01)

Health literacy in gastrointestinal diseases: a comparative analysis between patients with liver cirrhosis, inflammatory bowel disease and gastrointestinal cancer
by: Leonard Kaps, et al.
Published: (2022-12-01)

Targeting fibrosis and steatohepatitis through the metabolism – results from the ESSENCE trial
by: Maurice Michel, et al.
Published: (2025-09-01)

Comparison of Inflammatory Cytokine Levels in Hepatic and Jugular Veins of Patients with Cirrhosis
by: Leonard Kaps, et al.
Published: (2023-01-01)

Evaluation of ten diagnostic models for metabolic dysfunction-associated fatty liver disease in lean people living with HIV
by: Wei Xu, et al.
Published: (2025-09-01)

Thyroid Diseases and Thyroid Asymptomatic Dysfunction in People Living With HIV
by: Cristina Micali, et al.
Published: (2022-09-01)

Effect of Sex on Coronary Endothelial Dysfunction in People Living With HIV
by: Anum S. Minhas, et al.
Published: (2022-12-01)

Validation of the CLIF-C OF Score and CLIF-C ACLF Score to Predict Transplant-Free Survival in Patients with Liver Cirrhosis and Concomitant Need for Intensive Care Unit Treatment
by: Michael Nagel, et al.
Published: (2023-04-01)

A higher FIB‐4 index is associated with an increased incidence of renal failure in the general population
by: Eva Maria Schleicher, et al.
Published: (2022-12-01)

Elevated serum levels of glial fibrillary acidic protein are associated with covert hepatic encephalopathy in patients with cirrhosis
by: Simon Johannes Gairing, et al.
Published: (2023-04-01)

Sonographic assessment of low muscle quantity identifies mortality risk during COVID‐19: a prospective single‐centre study
by: Wolfgang M. Kremer, et al.
Published: (2022-02-01)

Editorial: Neurocognitive dysfunction in people living with HIV and the underlying brain mechanisms
by: Wei Wang, et al.
Published: (2025-08-01)

Prevalence and predictors of kidney dysfunction among people living with HIV in Tanzania.
by: Daniel Msilanga, et al.
Published: (2025-01-01)

The Frequency and Predictors of Sexual Dysfunction Among People Living with HIV/AIDS
by: Abdu Z, et al.
Published: (2023-12-01)

Polyamine metabolism impacts T cell dysfunction in the oral mucosa of people living with HIV
by: S. S. Mahalingam, et al.
Published: (2023-01-01)

Hepatic interleukin‐1 receptor type 1 signalling regulates insulin sensitivity in the early phases of nonalcoholic fatty liver disease
by: Nadine Gehrke, et al.
Published: (2022-09-01)

Sexual Dysfunctions Among People Living With HIV With Long-Term Treatment With Antiretroviral Therapy
by: Marco De Tubino Scanavino, PhD, et al.
Published: (2022-10-01)

Uncovering the NAFLD burden in people living with HIV from high‐ and middle‐income nations: a meta‐analysis with a data gap from Subsaharan Africa
by: Ramiro Manzano‐Nunez, et al.
Published: (2023-03-01)

Insulin Resistance across the Spectrum of Nonalcoholic Fatty Liver Disease
by: Angelo Armandi, et al.
Published: (2021-03-01)

Why do marital partners of people living with HIV not test for HIV? A qualitative study in Lusaka, Zambia
by: Maurice Musheke, et al.
Published: (2016-08-01)

Long-term potassium monitoring and dynamics in risk of liver dysfunction among people living with HIV
by: Hong Liu, et al.
Published: (2025-07-01)

Lymphomas in People Living with HIV
by: Emanuela Vaccher, et al.
Published: (2022-09-01)

Lipodystrophy and metabolic parameters of people living with HIV
by: Labibe do Socorro Haber de Menezes, et al.
Published: (2018-10-01)

The prevalence of nonalcoholic fatty liver disease in people living with HIV: a systematic review and meta-analysis
by: Jiaqi Wei, et al.
Published: (2025-02-01)

Predictors of Significant Fibrosis Among People Living with HIV with Metabolic Dysfunction- Associated Steatotic Liver Disease
by: Thaninee Prasoppokakorn, et al.
Published: (2024-12-01)

ROS-Induced Mitochondrial Dysfunction in CD4 T Cells from ART-Controlled People Living with HIV
by: Madison Schank, et al.
Published: (2023-04-01)

Metabolic Dysfunction-Associated Steatotic Liver Disease in People Living with HIV—Limitations on Antiretroviral Therapy Selection
by: Georgios Kalopitas, et al.
Published: (2024-06-01)

Risk Factors of Renal Tubular Dysfunction in Thai People Living with HIV Receiving Tenofovir Disoproxil Fumarate
by: Angsana Phuphuakrat MD, PhD, et al.
Published: (2022-10-01)

The Snoring Index Identifies Risk of Non-Alcoholic Fatty Liver Disease in Patients with Obstructive Sleep Apnea Syndrome
by: Katharina Bahr, et al.
Published: (2021-12-01)

Cancer screening in people living with HIV
by: Mar Masiá, et al.
Published: (2023-11-01)

Supporting homeless people living with HIV
by: Cameron Ailsa
Published: (2010-05-01)

Cardiovascular Prevention in People Living With HIV
by: Johanne Silvain, MD, PhD, et al.
Published: (2022-11-01)

Evolocumab, a PCSK9‐Monoclonal Antibody, Rapidly Reverses Coronary Artery Endothelial Dysfunction in People Living With HIV and People With Dyslipidemia
by: Thorsten M. Leucker, et al.
Published: (2020-07-01)

Article Commentary: Clinical Medicine: Endocrinology and Diabetes: Insulin Resistance–-a Link between Inflammation and Hepatocarcinogenesis?
by: Jörn M. Schattenberg
Published: (2009-01-01)